Yunnan Botanee Bio-Technology Group Co.LTD (SHE:300957)
China · Delayed Price · Currency is CNY 41.92
+1.04 (2.54%)
May 6, 2026, 3:04 PM CST
SHE:300957 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 543.34 | 505.72 | 503.05 | 756.8 | 1,051 | 862.92 |
Depreciation & Amortization | 183.75 | 183.75 | 189.82 | 137.89 | 58.23 | 58.53 |
Other Amortization | 83.89 | 83.89 | 44.44 | 37.2 | - | 14.86 |
Loss (Gain) From Sale of Assets | -2.57 | -2.57 | 5.04 | -0.46 | - | -0.52 |
Asset Writedown & Restructuring Costs | 34.55 | 34.55 | 115.69 | - | - | 0.04 |
Loss (Gain) From Sale of Investments | -106.25 | -106.25 | -99.97 | -47.12 | - | -29.63 |
Provision & Write-off of Bad Debts | -2.01 | -2.01 | 12.4 | 12.97 | - | - |
Other Operating Activities | 115.86 | 42.23 | -69.61 | 29.6 | -340.12 | 17.24 |
Change in Accounts Receivable | 263.42 | 263.42 | -310.03 | -348.62 | - | -45.1 |
Change in Inventory | 104.81 | 104.81 | 254.89 | -121.42 | - | -221.43 |
Change in Accounts Payable | -113.12 | -113.12 | 92.5 | 162.54 | - | 490.74 |
Change in Other Net Operating Assets | - | - | - | - | - | 5.27 |
Operating Cash Flow | 1,088 | 976.6 | 694.87 | 610.44 | 769.45 | 1,153 |
Operating Cash Flow Growth | 38.77% | 40.54% | 13.83% | -20.66% | -33.25% | 167.44% |
Capital Expenditures | -131.23 | -482.99 | -378.38 | -274.28 | -353.42 | -270.68 |
Sale of Property, Plant & Equipment | 0.31 | 0.31 | 3.48 | 2.89 | 0.01 | 0.23 |
Cash Acquisitions | - | - | 0.01 | -493.5 | -7.47 | -6.5 |
Investment in Securities | -197.98 | 253.85 | -758.94 | 188.09 | 261.69 | -2,300 |
Other Investing Activities | 83.95 | 90.7 | 49.91 | 58.75 | 80.71 | 18.83 |
Investing Cash Flow | -244.95 | -138.13 | -1,084 | -518.06 | -18.49 | -2,558 |
Long-Term Debt Issued | - | 742.48 | 837.71 | 105.45 | - | - |
Total Debt Issued | 815.1 | 742.48 | 837.71 | 105.45 | - | - |
Long-Term Debt Repaid | - | -773.11 | -388.87 | -100.64 | -64.72 | -42.89 |
Total Debt Repaid | -585.45 | -773.11 | -388.87 | -100.64 | -64.72 | -42.89 |
Net Debt Issued (Repaid) | 229.65 | -30.63 | 448.84 | 4.81 | -64.72 | -42.89 |
Issuance of Common Stock | - | - | - | - | - | 2,905 |
Repurchase of Common Stock | - | - | -124.88 | -109.84 | - | - |
Common Dividends Paid | -361.12 | -265.64 | -262.52 | -339.14 | -254.16 | -190.62 |
Other Financing Activities | -0.75 | -0.76 | -8.97 | -14.3 | -0.78 | -7.58 |
Financing Cash Flow | -132.22 | -297.03 | 52.47 | -458.47 | -319.66 | 2,664 |
Foreign Exchange Rate Adjustments | -7.49 | -2.1 | -1.23 | -0.72 | 0.03 | -0 |
Net Cash Flow | 703.18 | 539.34 | -337.82 | -366.81 | 431.32 | 1,258 |
Free Cash Flow | 956.62 | 493.61 | 316.48 | 336.16 | 416.02 | 882.04 |
Free Cash Flow Growth | 794.71% | 55.97% | -5.85% | -19.20% | -52.83% | 158.23% |
Free Cash Flow Margin | 17.30% | 9.21% | 5.52% | 5.87% | 8.30% | 21.93% |
Free Cash Flow Per Share | 2.26 | 1.17 | 0.76 | 0.80 | 0.98 | 2.17 |
Cash Income Tax Paid | 565.34 | 593.45 | 673.76 | 652.43 | 616.71 | 490.75 |
Levered Free Cash Flow | 765.97 | 279.4 | 91.17 | 70.03 | 30.36 | 612.5 |
Unlevered Free Cash Flow | 778.06 | 290.83 | 102.16 | 73.13 | 33.33 | 615.12 |
Change in Working Capital | 237.29 | 237.29 | -6 | -316.43 | - | 229.26 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.